Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Impres Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Impres Medical

Impres Medical

Seed

Impres Medical: Developing minimally invasive solutions for uterine bleeding since 1999.

HQ
Minnetonka, MN, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Impres Medical, founded in 1999 and based in Minnetonka, Minnesota, focuses on developing minimally invasive products for the treatment of abnormal uterine bleeding in women. The company's core mission is to provide innovative, less invasive medical solutions that improve women's health and quality of life. Their primary product offerings are designed to address gynecological conditions with minimal disruption to patients' lives, targeting a specialized market within women's healthcare.

Notable affiliated individuals and investors have not been publicly disclosed. Key achievements include the successful development and implementation of minimally invasive technologies that have positively impacted the treatment landscape for abnormal uterine bleeding. Impres Medical's contributions have significantly advanced options for women, offering safer and more effective alternatives to traditional surgical procedures.

Impres Medical - Similar Companies

Minerva Surgical logo

Minerva Surgical

Intact Medical logo

Intact Medical

Minnesota Medical Technologies logo

Minnesota Medical Technologies

mnmedtech.us

Impleo Medical logo

Impleo Medical

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

ImpriMed logo

ImpriMed

imprimedicine.com

EmboMedics logo

EmboMedics

Mirabilis Medica logo

Mirabilis Medica

Ionix Medical logo

Ionix Medical

Micro Medical Solutions logo

Micro Medical Solutions

Materna Medical logo

Materna Medical

Aurea Medical logo

Aurea Medical

EndoMetabolic Solutions logo

EndoMetabolic Solutions

endometabolic.com

GT Urological logo

GT Urological

Perspective Medical logo

Perspective Medical

Impres Medical - Quick Facts

Who are Impres Medical's competitors?

Companies similar to Impres Medical include Minerva Surgical, Intact Medical, Minnesota Medical Technologies and Impleo Medical.

When was Impres Medical founded?

Impres Medical was founded in 2000.

Where is Impres Medical's headquarters located?

Impres Medical's headquarters is located in Minnetonka, MN, US.

When was Impres Medical's last funding round?

Impres Medical's most recent funding round was for $3M (USD) in May 2010.

How much has Impres Medical raised to-date?

As of May 27, 2010, Impres Medical has raised a total of $5.3M (USD).

How many employees does Impres Medical have?

Impres Medical has 1 employee as of Feb 5, 2024.

Impres Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations